|
Volumn 97, Issue 3, 2005, Pages 166-167
|
Missing the target: Ubiquitin ligase drugs stall
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANAPHASE PROMOTING COMPLEX;
BORTEZOMIB;
CELL CYCLE PROTEIN;
CULLIN;
CYSTEINE PROTEINASE;
I KAPPA B KINASE;
IMATINIB;
LIGASE INHIBITOR;
MYC PROTEIN;
NEDD8 PROTEIN;
PROTEASOME;
PROTEASOME INHIBITOR;
PROTEIN MDM2;
PROTEIN P27;
PROTEIN P53;
S PHASE KINASE ASSOCIATED PROTEIN 2;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;
UBIQUITIN;
UBIQUITIN PROTEIN LIGASE;
UBIQUITIN PROTEIN LIGASE E3;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
MDM2 PROTEIN, HUMAN;
NEDD8 PROTEIN, HUMAN;
NUCLEAR PROTEIN;
ONCOPROTEIN;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CELL CYCLE;
CELL DAMAGE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG TARGETING;
DRUG TOLERABILITY;
ENZYME ACTIVATION;
ENZYME ACTIVE SITE;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
FOOD AND DRUG ADMINISTRATION;
GENE OVEREXPRESSION;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MULTIPLE MYELOMA;
NEUROPATHY;
NOTE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN METABOLISM;
PROTEIN TRANSPORT;
UBIQUITINATION;
UNITED STATES;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
HUMANS;
NUCLEAR PROTEINS;
PROTEASE INHIBITORS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
PYRAZINES;
UBIQUITIN-PROTEIN LIGASES;
UBIQUITINS;
|
EID: 13744260574
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/97.3.166 Document Type: Note |
Times cited : (20)
|
References (0)
|